You've searched: Collection: ehsl_novel_nam
1 - 25 of 1
Number of results to display per page
TitleCreatorDescriptionIdentifier
1 Baseline Characteristics of LHON Subjects in the RESCUE and REVERSE Phase III Gene Therapy TrialsMark Moster, Catherine Vignal, Nancy Newman, Alfredo Sadun, Patrick Yu-Wai-Man, Valerio Carelli, Thomas Klopstock, Adam Debusk, Robert Sergott, Molly Scannel Bryan, Jose-Alain Sahel, Barrett Katz, Scott UretskyRESCUE and REVERSE are Phase‑ III, randomized, multicenter, double‑masked, sham‑ controlled trials of rAAV2/2-ND4, an intravitreally injected gene therapy for treatment of ND4‑ LHON. RESCUE subjects had vision loss for ≤6 months and REVERSE subjects from >6 months up to 1 year.20180306_nanos_posters_161
1 - 25 of 1